Manufacturing news briefs – stories you might have missed

Jatenergy records record sales

Australian dairy and consumer goods exporter Jatenergy (JAT) has recorded its highest-ever monthly sales in February driven by the emergence of coronavirus in China. The company reported February revenue of $8.3 million led by sales of its Neurio lactoferrin brand. The company expects sales to remain strong over coming months. Expansion of JAT’s Australian Natural Milk Association manufacturing facility (pictured) in western Melbourne was completed in February and will contriobute to sales in March.

Orthocell in successful bone repair study

Regenerative medicine company Orthocell has completed a US FDA regulatory study demonstrating successful bone growth using its CelGro surgical device. CelGro, a collagen medical device which facilitates tissue repair, has previously been shown to assist bone growth around dental implants. The latest study at the University of Western Australia and the Texas A&M University should speed US approval to further commercialise the product.

Orbital to receive $3 million in patent case

Perth’s Orbital Corporation is to receive $3 million in settlement of a patent dispute in the United States. The cash will be paid by Daimler AG, Mercedes Benz and Robert Bosch as a result of the case brought by Orbital in the state of Michigan. Orbital manufactures propulsion systems for unmanned aerial vehicles (UAVs).

Little Green Pharma the latest to secure medicinal cannabis licence

Medicinal cannabis grower Little Green Pharma has been given a manufacturing licence by Australia’s Office of Drug Control. The Western Australian company can now cultivate and produce medicinal cannabis products in addition to the three for which it already holds export permits. In February the company announced it would supply cannabis oils and flowers to a German group.

Picture: Jatenergy

Subscribe to our free @AuManufacturing newsletter here.